GNI Group Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares GNI Group Limited with three other
companies in this sector in Japan:
Greenpeptide Co Ltd
sales of 821.63 million Japanese Yen [US$7.17 million]
Onco Therapy Science, Inc
(769.96 million Japanese Yen [US$6.72 million]
of which 100%
was Research & Development In Medical), and
PhoenixBio Co Ltd
(881.04 million Japanese Yen [US$7.69 million]
GNI Group Limited reported sales of ¥1.02 billion (US$8.88 million)
December of 2015.
increase of 114.2%
versus 2014, when the company's sales were ¥474.72 million.
This was the fourth straight year of sales growth at GNI Group Limited.
Sales of Operating Segment -China saw an increase
114.9% in 2015, from
¥462.17 million to ¥993.23 million.